/ /

  • linkedin
  • Increase Font
  • Sharebar

    In-office MGD treatments may provide relief but lack formal studies

    Patients must play a role in MGD care; surgeons need a systematic treatment approach


    Yet, another MGD treatment is intense pulsed light, for which there is a paucity of published data for ophthalmic indications, Dr. Davidson said.

    However, some research has shown a reduction in artificial tear usage, a decrease in the Ocular Surface Disease Index score, and a reduction in lid margin edema and vascularity. Patients must return for maintenance treatments every 6 months to a year.

    Finally, Dr. Davidson addressed intraductal meibomian gland probing, in which one study reported 96% of the 25 patients included had immediate post-probing relief. However, the treatment can be painful, he added.

    One drawback that may hurt in-office treatments for MGD is cost and reimbursement, Dr. Davidson said.


    Richard S. Davidson, MD

    E: [email protected]

    This article was adapted from Dr. Davidson’s presentation at Cornea Subspecialty Day during the 2015 meeting of the American Society of Cataract and Refractive Surgery. Dr. Davidson has no financial interest in the subject matter.




    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results